Biotech Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022 December 9, 2022
Biotech ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares December 9, 2022
Biotech CLASS ACTION UPDATE for EIGR, CURV and IREN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders December 9, 2022
Biotech Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update December 8, 2022
Biotech ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EIGR December 8, 2022
Biotech EIGER BIOPHARMACEUTICALS, INC. (EIGR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (EIGR) December 8, 2022
Biotech CNS Pharmaceuticals Announces Preliminary Results from Ongoing Potentially Pivotal Trial Evaluating Berubicin for the Treatment of Recurrent Glioblastoma Multiforme (GBM) December 8, 2022
Biotech Eiger BioPharmaceuticals Investors: Please contact the Portnoy Law Firm to recover your losses, January 9, 2023 deadline December 8, 2022
Biotech Immutep Successfully Achieves Commercial Scale in Manufacturing of Eftilagimod Alpha December 8, 2022
Search
life sciences
December 9, 2022
December 9, 2022
December 9, 2022
December 9, 2022
December 8, 2022
December 8, 2022
December 8, 2022
December 8, 2022
December 8, 2022
December 8, 2022
